Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Stefan O. Ciurea, Dean A. Lee, Cecele Denman, Jolie Schafer, Roland L Bassett, Kai Cao, Gabriela Rondon, Julianne Chen, Doris Soebbing, Dana B. Willis, Sairah Ahmed, Qaiser Bashir, Partow Kebriaei, Issa F. Khouri, Betul Oran, Simrit Parmar, Uday R. Popat, Chitra Hosing, Eric Yvon, Katayoun Rezvani, Elizabeth J. Shpall, Richard E. Champlin
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2755276028